Status:
COMPLETED
Supplementation With Lactoferrin in Preterm Newborns
Lead Sponsor:
University of Siena
Conditions:
Prematurity
Low Birth Weight
Eligibility:
All Genders
23-32 years
Phase:
PHASE4
Brief Summary
The main objective of the study is to evaluate the antioxidant effect of lactoferrin and its ability to reduce free radicals related diseases in the newborn. This evaluation will be done through the a...
Detailed Description
The study arises from the need to structure care to identify a product natural with antioxidant propriety that may reduce the extent of damage in perinatal neurological disorders related to oxidative ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Newborns with a birthweight ≤ 1500 grand/or gestational age ≤ 32 weeks
- Sign of the informed consent by parents
- Exclusion criteria:
- Fetal-onset disorders and/or recognizable at birth
- Milk intolerance
- Family history of allergies
- Use of infant formula supplemented with lactoferrin
Exclusion
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT01172236
Start Date
January 1 2011
End Date
January 1 2013
Last Update
March 26 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.